These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2767956)

  • 1. Protection from O,O,S-trimethyl phosphorothioate-induced immune suppression.
    Rodgers KE; Haviland DL; Ware CF
    Immunopharmacology; 1989; 17(3):131-40. PubMed ID: 2767956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1986 Dec; 12(3):193-202. PubMed ID: 3493228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):310-8. PubMed ID: 3877352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute administration of O,S,S-trimethyl phosphorodithioate on the generation of cellular and humoral immune responses following in vitro stimulation.
    Rodgers KE; Leung N; Ware CF
    Toxicology; 1988 Oct; 51(2-3):241-53. PubMed ID: 3051516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animals.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):270-81. PubMed ID: 3494328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affected.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):171-80. PubMed ID: 2939039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate.
    Gandy J; Imamura T
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):498-508. PubMed ID: 3564023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of O,S,S-trimethyl phosphorodithioate on immune function.
    Rodgers KE; Leung N; Ware CF; Imamura T
    Toxicology; 1987 Feb; 43(2):201-16. PubMed ID: 3492784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effect of an impurity of malathion: inhibition of murine T- and B-lymphocyte responses by O,O,S-trimethyl phosphorothioate.
    Thomas IK; Imamura T
    Toxicol Appl Pharmacol; 1986 May; 83(3):456-64. PubMed ID: 2939594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute administration of O,O,S-trimethyl phosphorothioate on the respiratory burst and phagocytic activity of splenic and peritoneal leukocytes.
    Rodgers KE; Ellefson DD
    Agents Actions; 1988 Jun; 24(1-2):152-60. PubMed ID: 2841830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subacute administration of O,S,S-trimethyl phosphorodithioate on cellular and humoral immune response systems.
    Rodgers KE; Stern ML; Ware CF
    Toxicology; 1989 Feb; 54(2):183-95. PubMed ID: 2784238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of macrophage protease activity by acute administration of O,O,S trimethyl phosphorothioate.
    Rodgers KE; Ellefson DD
    Agents Actions; 1990 Mar; 29(3-4):277-85. PubMed ID: 2160188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigen.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):181-9. PubMed ID: 3833856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced levels of lipid peroxidation and xanthine oxidase activity in the lung of male Sprague-Dawley rats following treatment with O,O,S-trimethyl phosphorothioate.
    Ohtaka K; Koizumi A
    Pharmacol Toxicol; 1994; 75(3-4):206-11. PubMed ID: 7800664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogenesis of O,O,S-trimethyl phosphorothioate-induced pulmonary injury in mice.
    Durham SK; Imamura T
    Toxicol Appl Pharmacol; 1988 Dec; 96(3):417-28. PubMed ID: 3206524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term morphologic and biochemical changes induced by O,O,S-trimethyl phosphorothioate in the rat lung.
    Durham SK; Gijbels MJ
    Toxicol Appl Pharmacol; 1989 May; 98(3):465-74. PubMed ID: 2718175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular responses to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats.
    Gandy J; Imamura T
    Toxicol Appl Pharmacol; 1985 Aug; 80(1):51-7. PubMed ID: 4024107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of metabolic activation, covalent binding, and glutathione depletion in pulmonary toxicity produced by an impurity of malathion.
    Imamura T; Hasegawa L
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):476-83. PubMed ID: 6710498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct involvement of the central nervous system in hypophagia and inhibition of respiratory rate in rats after treatment with O,O,S-trimethyl phosphorothioate.
    Ohtaka K; Hamade N; Yamazaki Y; Suzuki M; Koizumi A
    Arch Toxicol; 1995; 69(8):559-64. PubMed ID: 8534200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal death and lung injury in rats caused by intrauterine exposure to O,O,S-trimethylphosphorothioate.
    Koizumi A; Montalbo M; Nguyen O; Hasegawa L; Imamura T
    Arch Toxicol; 1988 Apr; 61(5):378-86. PubMed ID: 3395249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.